PFE (STOCKS)
Pfizer Inc.
$27.710000
+0.100000 (+0.36%)
Prev close: $27.610000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Albert Bourla
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $159,808.30M
- Employees
- 81,000
- P/E (TTM)
- 20.30
- P/B (TTM)
- 1.69
- Dividend Yield
- 622.96%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
10
Buy
17
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.66 | $0.58 | +0.0825 | +14.29% |
|
Sep 2025 (Q3)
|
$0.87 | $0.64 | +0.2303 | +36.00% |
|
Jun 2025 (Q2)
|
$0.78 | $0.59 | +0.1931 | +32.90% |
|
Mar 2025 (Q1)
|
$0.92 | $0.67 | +0.2507 | +37.46% |
Financial Statements
| Revenues | $62.79B |
| Benefits Costs and Expenses | $53.63B |
| Cost Of Revenue | $16.70B |
| Costs And Expenses | $53.63B |
| Gross Profit | $46.08B |
| Operating Expenses | $36.93B |
| Selling, General, and Administrative Expenses | $13.91B |
| Other Operating Expenses | $23.02B |
| Operating Income/Loss | $9.15B |
| Income/Loss From Continuing Operations After Tax | $9.84B |
| Income/Loss From Continuing Operations Before Tax | $9.15B |
| Income/Loss From Discontinued Operations Net Of Tax | $32.00M |
| Income Tax Expense/Benefit | -$685.00M |
| Income Tax Expense/Benefit, Deferred | -$2.10B |
| Interest Expense, Operating | $2.70B |
| Net Income/Loss | $9.87B |
| Net Income/Loss Attributable To Noncontrolling Interest | $41.00M |
| Net Income/Loss Attributable To Parent | $9.83B |
| Net Income/Loss Available To Common Stockholders, Basic | $9.83B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.73 |
| Diluted Earnings Per Share | $1.72 |
| Basic Average Shares | 5,683,000,000 |
| Diluted Average Shares | 5,711,000,000 |
| Assets | $208.73B |
| Current Assets | $46.92B |
| Inventory | $11.47B |
| Other Current Assets | $35.46B |
| Noncurrent Assets | $161.81B |
| Fixed Assets | $18.88B |
| Intangible Assets | $51.32B |
| Other Non-current Assets | $91.60B |
| Liabilities | $115.64B |
| Current Liabilities | $36.60B |
| Accounts Payable | $5.02B |
| Wages | $3.04B |
| Other Current Liabilities | $28.54B |
| Noncurrent Liabilities | $79.04B |
| Equity | $93.10B |
| Equity Attributable To Noncontrolling Interest | $295.00M |
| Equity Attributable To Parent | $92.80B |
| Liabilities And Equity | $208.73B |
| Net Cash Flow From Operating Activities | $13.08B |
| Net Cash Flow From Operating Activities, Continuing | $13.08B |
| Net Cash Flow From Investing Activities | $3.17B |
| Net Cash Flow From Investing Activities, Continuing | $3.17B |
| Net Cash Flow From Financing Activities | -$16.01B |
| Net Cash Flow From Financing Activities, Continuing | -$16.01B |
| Exchange Gains/Losses | $7.00M |
| Net Cash Flow | $242.00M |
| Net Cash Flow, Continuing | $235.00M |
| Comprehensive Income/Loss | $9.79B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $56.00M |
| Comprehensive Income/Loss Attributable To Parent | $9.73B |
| Other Comprehensive Income/Loss | -$80.00M |